medline.ch Dermatologie Tumoren
Leaderboard

En | De
Sie sind hier: Dermatologie » Tumoren 18. Mai 2022
Suchen
medline.ch
Tumoren
Erweiterte Suche
Dermatologie
Akne
Alopezie
Dermatitis
Infektionen
Photosensitive Erkrankungen
Psoriasis
Tumoren
Melanom
Anderes
Ulcus
Urtikaria
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 6063  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 121244  
   
ASO Visual Abstract: An Evidence-Based Staging System for Mucosal Melanoma: a Proposal.
Ann Surg Oncol
Cui C, Lian B, Zhang X, Wu D, Li K, Si L, Yang Y, Tian H, Zhou L, Chi Z, Sheng X, Kong Y, Mao L, Wang X, Bai X, Yan X, Li S, Dai J, Tang B, Wei X, Gershenwald JE, Balch CM, Guo J.
PMID: 35579763 [PubMed - as supplied by publisher]


Female melanoma and estrogen receptors expression: an immunohistochemical pilot study.
Melanoma Res
Dika E, Lambertini M, Lauriola M, Veronesi G, Ricci C, Tartari F, Tassone D, Campione E, Scarfì F.
PMID: 35579670 [PubMed - as supplied by publisher]


Factors Related to Delayed Diagnosis of Cutaneous Melanoma in the Brazilian Public Health System.
J Cancer Educ
Paula Bhering Nogueira A, Drummond-Lage AP, Drumond Ribeiro GP, Ferreira Leite E, Henrique Xavier M, Julius Alves Wainstein A.
PMID: 35578128 [PubMed - as supplied by publisher]


The roles of TGF-β and VEGF pathways in the suppression of antitumor immunity in melanoma and other solid tumors.
Pharmacol Ther
Bu MT, Chandrasekhar P, Ding L, Hugo W.
PMID: 35577211 [PubMed - as supplied by publisher]


Loss of 'Epidermal Melanin Unit' Integrity in Human Skin During Melanoma-Genesis.
Front Oncol
Casalou C, Moreiras H, Mayatra JM, Fabre A, Tobin DJ.
PMID: 35574390 [PubMed]


Assessment of the Novel, Practical, and Prognosis-Relevant TNM Staging System for Stage I-III Cutaneous Melanoma.
Front Oncol
Hu D, Liu Z, Chen S, Huang Y, Zeng W, Wei W, Zhang C, Zhou L, Chen D, Wu Y, Guo L.
PMID: 35574383 [PubMed]


Sun Protection Behavior in Danish Outdoor Workers Following a Multicomponent Intervention.
Front Public Health
Jakobsen MM, Mortensen OS, Grandahl K.
PMID: 35570895 [PubMed - indexed for MEDLINE]


European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022.
Eur J Cancer
Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Basset-Seguin N, Bastholt L, Bataille V, Del Marmol V, Dréno B, Fargnoli MC, Forsea AM, Grob JJ, Höller C, Kaufmann R, Kelleners-Smeets N, Lallas A, Lebbé C, Lytvynenko B, Malvehy J, Moreno-Ramirez D, Nathan P, Pellacani G, Saiag P, Stratigos AJ, Van Akkooi ACJ, Vieira R, Zalaudek I, Lorigan P, European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO), and the European Organization for Research and Treatment of Cancer (EORTC)..
PMID: 35570085 [PubMed - as supplied by publisher]


Single agent Talimogene Laherparepvec for stage IIIB-IVM1c melanoma patients: a systematic review and meta-analysis.
Crit Rev Oncol Hematol
Stahlie EHA, Mulder EEAP, Reijers S, Balduzzi S, Zuur CL, Klop WMC, van der Hiel B, Van de Wiel BA, Wouters MWJM, Schrage YM, van Houdt WJ, Grunhagen DJ, van Akkooi ACJ.
PMID: 35569723 [PubMed - as supplied by publisher]


Biomarker-driven therapies for metastatic uveal melanoma: A prospective precision oncology feasibility study.
Eur J Cancer
Leyvraz S, Konietschke F, Peuker C, Schütte M, Kessler T, Ochsenreither S, Ditzhaus M, Sprünken ED, Dörpholz G, Lamping M, Rieke DT, Klinghammer K, Burock S, Ulrich C, Poch G, Schäfer R, Klauschen F, Joussen A, Yaspo ML, Keilholz U.
PMID: 35569281 [PubMed - as supplied by publisher]


Association between hypertension and cutaneous melanoma, and the effect of aspirin: extended follow-up of a large randomised controlled trial.
Cancer Epidemiol
Yan MK, Orchard SG, Adler NR, Wolfe R, McLean C, Rodríguez LM, Woods RL, Gibbs P, Chan AT, Haydon A, Mar VJ.
PMID: 35567859 [PubMed - as supplied by publisher]


The significance of intratumoural CD163+ macrophages in oral malignant melanoma: A preliminary study.
Oral Dis
Kodama T, Shigeoka M, Nishio M, Koma YI, Akashi M, Yokozaki H.
PMID: 35567533 [PubMed - as supplied by publisher]


Bis-Cinnamamide Derivatives as APE/Ref-1 Inhibitors for the Treatment of Human Melanoma.
Molecules
Alhazmi R, Tong S, Darwish S, Khanjani E, Khungar B, Chawla S, Zheng Z, Chamberlin R, Parang K, Yang S.
PMID: 35566022 [PubMed - indexed for MEDLINE]


Prognostic Value of IGF2 mRNA-Binding Protein 3 (IGF2BP3) Intratumoral Expression in Melanoma Patients at the Time of Diagnosis: Comparative Analysis of RT-qPCR Versus Immunohistochemistry.
Cancers (Basel)
Sánchez-Sendra B, Pérez-Debén S, González-Muñoz JF, Murgui A, Monteagudo C.
PMID: 35565448 [PubMed]


Potential Biomarkers of Skin Melanoma Resistance to Targeted Therapy-Present State and Perspectives.
Cancers (Basel)
Olbryt M.
PMID: 35565444 [PubMed]


Proton Pump Inhibitor Use and Efficacy of Nivolumab and Ipilimumab in Advanced Melanoma.
Cancers (Basel)
Homicsko K, Dummer R, Hoeller C, Wolchok JD, Hodi FS, Larkin J, Ascierto PA, Atkinson V, Robert C, Postow MA, Re S, Paulucci D, Dobler D, Michielin O.
PMID: 35565428 [PubMed]


The Genetic Basis of Dormancy and Awakening in Cutaneous Metastatic Melanoma.
Cancers (Basel)
Janowska A, Iannone M, Fidanzi C, Romanelli M, Filippi L, Del Re M, Martins M, Dini V.
PMID: 35565234 [PubMed]


The Role of Treatment Sequencing with Immune-Checkpoint Inhibitors and BRAF/MEK Inhibitors for Response and Survival of Patients with BRAFV600-Mutant Metastatic Melanoma-A Retrospective, Real-World Cohort Study.
Cancers (Basel)
Haist M, Stege H, Ebner R, Fleischer MI, Loquai C, Grabbe S.
PMID: 35565212 [PubMed]


The Lysosome in Malignant Melanoma: Biology, Function and Therapeutic Applications.
Cells
Hsu CH, Lee KJ, Chiu YH, Huang KC, Wang GS, Chen LP, Liao KW, Lin CS.
PMID: 35563798 [PubMed - indexed for MEDLINE]


Novel Therapeutic Approaches with DNA Damage Response Inhibitors for Melanoma Treatment.
Cells
Maresca L, Stecca B, Carrassa L.
PMID: 35563772 [PubMed - in process]


   
   Artikel 1 - 20 / 121244    Seite 1 von 6063  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Benutzername

Passwort

 

 

Haben Sie Ihr Passwort vergessen?

 

Neu bei My Medline?

Melden Sie sich bei My Medline an!

 

Mehr über My Medline erfahren

mehr >>

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1